VINBLASTINE News

VINBLASTINE currently has 8 news articles, with 38 predicted indications.

This page combines the AI-predicted indications for VINBLASTINE with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

Evidence level: L5
Predicted indications (38):
- mantle cell lymphoma (99.0%)
- localized pagetoid reticulosis (99.0%)
- classic Hodgkin lymphoma (99.0%)
- primary cutaneous T-cell lymphoma (99.0%)
- Hodgkins lymphoma (99.0%)
- non-Hodgkin lymphoma (99.0%)
- Langerhans cell histiocytosis (99.0%)
- letterer-Siwe disease (99.0%)
- seminoma (99.0%)
- testicular cancer (99.0%)
- granulomatous slack skin disease (99.0%)
- yolk sac tumor (99.0%)
- lymphoma (99.0%)
- gestational trophoblastic neoplasm (99.0%)
- obsolete Hodgkin's granuloma (99.0%)
- Kaposi's sarcoma (disease) (99.0%)
- mycosis fungoides and variants (99.0%)
- classic Hodgkin lymphoma, lymphocyte-rich type (99.0%)
- B-cell neoplasm (99.0%)
- testicular germ cell tumor (99.0%)
- female breast carcinoma (99.0%)
- Hodgkin's paragranuloma (99.0%)
- testicular teratoma (99.0%)
- spermatocytic seminoma (99.0%)
- folliculotropic mycosis fungoides (99.0%)
- testicular seminoma (99.0%)
- lymphosarcoma (99.0%)
- lymphoma, non-Hodgkin, familial (99.0%)
- rhabdomyosarcoma (disease) (99.9%)
- botryoid-type embryonal rhabdomyosarcoma of the vagina (99.8%)
- parameningeal embryonal rhabdomyosarcoma (99.8%)
- embryonal extrahepatic bile duct rhabdomyosarcoma (99.8%)
- prostate embryonal rhabdomyosarcoma (99.8%)
- extrahepatic bile duct rhabdomyosarcoma (99.8%)
- liver sarcoma (99.8%)
- monocytic leukemia (99.8%)
- neuroblastoma (99.1%)
- ganglioneuroblastoma (disease) (99.1%)